KD-370 Phase II study.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 21 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 07 Jun 2016 New trial record